SCHEMBL6715667

SCHEMBL6715667

O=Cc1cc(Cl)c([N+](=O)[O-])c(Cl)c1

nearest known ligand 0.61

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 5/20 0.61
TSHR P16473 3/20 0.61
VCAM1 P19320 1/20 0.53
XDH P47989 1/20 0.44
ALDH5A1 P51649 1/20 0.40
ABAT P80404 1/20 0.40
KDM4A O75164 1/20 0.39
KDM4B O94953 1/20 0.39
DCTPP1 Q9H773 1/20 0.38
GRIN2D O15399 2/20 0.38
GRIN3B O60391 2/20 0.38
GRIN1 Q05586 2/20 0.38
GRIN2A Q12879 2/20 0.38
GRIN2B Q13224 2/20 0.38
GRIN2C Q14957 2/20 0.38
GRIN3A Q8TCU5 2/20 0.38
HSD17B10 Q99714 1/20 0.38
MAPK1 P28482 1/20 0.36
NPC1 O15118 1/20 0.36
LMNA P02545 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL954217 0.77 ALDH1A1 (1.00) ALDH1A1TSHRGRIN2DGRIN3BGRIN1
SCHEMBL28303467 0.76 XDH (0.60) ALDH1A1TSHRVCAM1XDHALDH5A1
SCHEMBL531545 0.75 XDH (0.69) ALDH1A1VCAM1XDHALDH5A1ABAT
SCHEMBL31357006 0.75 VCAM1 (0.59) ALDH1A1TSHRVCAM1XDHALDH5A1
SCHEMBL9427988 0.75 ALDH1A1 (0.70) ALDH1A1TSHRVCAM1HSD17B10LMNA
SCHEMBL1814040 0.74 ALDH1A1 (0.50) ALDH1A1TSHRVCAM1XDHALDH5A1
SCHEMBL10951439 0.74 VCAM1 (0.63) ALDH1A1TSHRVCAM1XDHALDH5A1
SCHEMBL19970551 0.74 XDH (0.48) ALDH1A1TSHRVCAM1XDHALDH5A1
SCHEMBL3113789 0.74 VCAM1 (0.73) ALDH1A1TSHRVCAM1XDHALDH5A1
SCHEMBL203116 0.74 TSHR (0.67) ALDH1A1TSHRVCAM1GRIN2DGRIN3B

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20040039208-A1 Process for making n-aryl-anthranilic acids and their derivatives CHEN MICHAEL HUAI GU (US) 2004-02-26 US disclosed
EP-1313694-A1 PROCESS FOR MAKING N-ARYL-ANTHRANILIC ACIDS AND THEIR DERIVATIVES WARNER-LAMBERT COMPANY (US) 2003-05-28 EP disclosed
WO-2002018319-A1 PROCESS FOR MAKING N-ARYL-ANTHRANILIC ACIDS AND THEIR DERIVATIVES WARNER-LAMBERT COMPANY LLC (US) 2002-03-07 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20040039208-A1 Process for making n-aryl-anthranilic acids and their derivatives AADAC, AHR, AADAT ALDH1A1 371/4885TSHR 2180/4885VCAM1 4371/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.